Genetics of primary brain tumors: a review

[1]  E. Newcomb,et al.  Loss of Heterozygosity with Mutation Frequency p 53 Mutations in Human Malignant Gliomas : Comparison of Updated , 2006 .

[2]  C. Turnbull,et al.  Genetic predisposition to cancer. , 2005, Clinical medicine.

[3]  F. Weber,et al.  Changes of telomere lengths in human intracranial tumours , 1993, Human Genetics.

[4]  H. Saya,et al.  Neurofibromatosis type 1 (NF1) gene: Implication in neuroectodermal differentiation and genesis of brain tumors , 1991, Cancer and Metastasis Reviews.

[5]  B. Zoll,et al.  Amplification of the c-erbB oncogene is associated with malignancy in primary tumours of neuroepithelial tissue , 1991, Journal of Neurology.

[6]  P. Vieregge,et al.  Familial glioma: occurrence within the “familial cancer syndrome” and systemic malformations , 1987, Journal of Neurology.

[7]  R. Gorlin.  Nevoid Basal‐Cell Carcinoma Syndrome , 1987, Dermatologic clinics.

[8]  D. Kwiatkowski,et al.  Tuberous sclerosis. , 1994, Archives of dermatology.

[9]  Erwin G. Van Meir,et al.  Turcot's syndrome of glioma and polyposis occurs in the absence of germ line mutations of exons 5 to 9 of the p53 gene. , 1993, Cancer research.

[10]  D. Louis,et al.  Comparative Study of p53 Gene and Protein Alterations in Human Astrocytic Tumors , 1993, Journal of neuropathology and experimental neurology.

[11]  R. Cawthon,et al.  The neurofibromatosis type 1 gene. , 1993, Annual review of neuroscience.

[12]  D. Ellison,et al.  Expression of the p53 protein in a spectrum of astrocytic tumours , 1992, The Journal of pathology.

[13]  E. Oldfield,et al.  Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas. , 1992, Cancer research.

[14]  D. Fults,et al.  Chromosome 11p15 deletions in human malignant astrocytomas and primitive neuroectodermal tumors. , 1992, Genomics.

[15]  B. Scheithauer,et al.  Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas , 1992, Genes, chromosomes & cancer.

[16]  M. Oren.  p53: the ultimate tumor suppressor gene? , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  M. Chiba,et al.  Brain tumor in a pedigree of cancer family syndrome. , 1992, Internal medicine.

[18]  A. Akbaşak,et al.  Oncogenes: cause or consequence in the development of glial tumors , 1992, Journal of the Neurological Sciences.

[19]  D. Cox,et al.  Analysis of chromosome 22 deletions in neurofibromatosis type 2-related tumors. , 1992, American journal of human genetics.

[20]  M. Kastan,et al.  Wild-type p53 is a cell cycle checkpoint determinant following irradiation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[21]  E. Oldfield,et al.  Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors. , 1992, Cancer research.

[22]  I. Petersen,et al.  Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas. , 1992, Cancer research.

[23]  S. Friend,et al.  Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. Fodde,et al.  Genetic evidence that Turcot syndrome is not allelic to familial adenomatous polyposis. , 1992, American journal of medical genetics.

[25]  A. Friedman,et al.  Loss of heterozygosity for 10q loci in human gliomas , 1992, Genes, chromosomes & cancer.

[26]  J. Biegel,et al.  Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors. , 1992, Cancer research.

[27]  A. Raap,et al.  Interphase cytogenetics: a new tool for the study of genetic changes in brain tumors. , 1992, Journal of neurosurgery.

[28]  B. Seizinger,et al.  Molecular genetics of neurological tumours. , 1992, Journal of medical genetics.

[29]  Droz Jp,et al.  [Renal cell cancer: oncogenes and tumor suppressor genes]. , 1992 .

[30]  C. James,et al.  Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[31]  I. Petersen,et al.  p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. , 1992, Cancer research.

[32]  山川 和弘.  A detailed deletion mapping of the short arm of chromosome 3 in sporadic renal cell carcinoma , 1992 .

[33]  G. Fuller,et al.  Amplified cellular oncogenes in neoplasms of the human central nervous system. , 1992, Mutation research.

[34]  O. Olopade,et al.  Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas. , 1992, Cancer research.

[35]  A. McMichael,et al.  Risk factors for tumors of the brain and meninges: Results from the Adelaide adult brain tumor study , 1992, International journal of cancer.

[36]  M. Greene,et al.  Developmental defects in gorlin syndrome related to a putative tumor suppressor gene on chromosome 9 , 1992, Cell.

[37]  E. Levine,et al.  Familial pheochromocytomas with unusual associations. , 1992, Journal of pediatric surgery.

[38]  P. Humphrey,et al.  Structural alterations of the epidermal growth factor receptor gene in human gliomas. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[39]  R. Lebo,et al.  Loss of heterozygosity at chromosome 1q22 in basal cell carcinomas and exclusion of the basal cell nevus syndrome gene from this site. , 1992, Cancer research.

[40]  D. Evans,et al.  Location of gene for Gorlin syndrome , 1992, The Lancet.

[41]  V. Sheffield,et al.  Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis. , 1992, American journal of human genetics.

[42]  R. Cawthon,et al.  p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. , 1992, Cancer research.

[43]  G. Thiel,et al.  Karyotypes in 90 human gliomas. , 1992, Cancer genetics and cytogenetics.

[44]  J. Moossy,et al.  Amplification of Epidermal Growth Factor Receptor Gene in Gliomas: Histopathology and Prognosis , 1992, Journal of neuropathology and experimental neurology.

[45]  J. Droz,et al.  [Renal cell cancer: oncogenes and tumor suppressor genes]. , 1992, La Revue du praticien.

[46]  J. Bruner,et al.  Alternative splicing of neurofibromatosis type 1 gene transcript in malignant brain tumors: PCR analysis of frozen‐section mRNA , 1992, Molecular carcinogenesis.

[47]  A. Børresen.  Oncogenesis in ovarian cancer , 1992, Acta obstetricia et gynecologica Scandinavica. Supplement.

[48]  B. Vogelstein,et al.  Participation of p53 protein in the cellular response to DNA damage. , 1991, Cancer research.

[49]  P. Kleihues,et al.  p53 mutations in nonastrocytic human brain tumors. , 1991, Cancer research.

[50]  J. Haines,et al.  Localization of one gene for tuberous sclerosis within 9q32-9q34, and further evidence for heterogeneity. , 1991, American journal of human genetics.

[51]  H. Saya,et al.  Differential expression of two types of the neurofibromatosis type 1 (NF1) gene transcripts related to neuronal differentiation. , 1991, Oncogene.

[52]  P. Humphrey,et al.  Deletion-mutant epidermal growth factor receptor in human gliomas: effects of type II mutation on receptor function. , 1991, Biochemical and biophysical research communications.

[53]  M. Lerman,et al.  Mapping of the von Hippel-Lindau disease locus to a small region of chromosome 3p by genetic linkage analysis. , 1991, Genomics.

[54]  R. Katakura,et al.  Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products. , 1991, Oncogene.

[55]  C. Crowson,et al.  Causes of death in patients with tuberous sclerosis. , 1991, Mayo Clinic proceedings.

[56]  B. Ponder.  Genetic predisposition to cancer. , 1991, British Journal of Cancer.

[57]  M. Pike,et al.  From gene to carcinogen: a rapidly evolving field in molecular epidemiology. , 1991, Cancer research.

[58]  N. Morton,et al.  Von Hippel-Lindau disease: a genetic study. , 1991, Journal of medical genetics.

[59]  B. Scheithauer,et al.  Subependymal giant cell astrocytoma: a clinical, pathological, and flow cytometric study. , 1991, Neurosurgery.

[60]  Burkholder Rr.  von Hippel-Lindau disease (angiomatosis of the retina and cerebellum). , 1991 .

[61]  S. Klauck,et al.  Genetic flanking markers refine diagnostic criteria and provide insights into the genetics of Von Hippel Lindau disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[62]  A. Raap,et al.  Interphase cytogenetics of brain tumors , 1991, Genes, chromosomes & cancer.

[63]  M. Noble,et al.  Retinoblastoma gene deletions in human glioblastomas. , 1991, Oncogene.

[64]  A. Levine,et al.  Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. , 1991, Genes & development.

[65]  L. Strong,et al.  Genetic epidemiology of childhood brain tumors , 1991, Genetic epidemiology.

[66]  B. Scheithauer,et al.  [Subependymal giant cell astrocytoma]. , 1991, Zentralblatt fur Pathologie.

[67]  L. Strong,et al.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. , 1990, Science.

[68]  R. White,et al.  Allelotype of human malignant astrocytoma. , 1990, Cancer research.

[69]  Margaret Robertson,et al.  The neurofibromatosis type 1 gene encodes a protein related to GAP , 1990, Cell.

[70]  P. O'Connell,et al.  Identification and characterization of transcripts from the neurofibromatosis 1 region: the sequence and genomic structure of EVI2 and mapping of other transcripts. , 1990, Genomics.

[71]  D. Bigner,et al.  Cytogenetics of human brain tumors. , 1990, Cancer genetics and cytogenetics.

[72]  B. Brownstein,et al.  Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. , 1990, Science.

[73]  P. O'Connell,et al.  Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus , 1990, Cell.

[74]  B. Vogelstein,et al.  GENE AMPLIFICATION IN HUMAN GLIOMAS: 178 , 1990 .

[75]  C. Nass,et al.  Gestational and familial risk factors for childhood astrocytoma: results of a case-control study. , 1990, Cancer research.

[76]  C. Mathew,et al.  Paternal origin of new mutations in Von Recklinghausen neurofibromatosis , 1990, Nature.

[77]  G. Barger,et al.  Familial factors associated with malignant gliomas , 1990, Genetic epidemiology.

[78]  F. Collins,et al.  Mutations in the p53 gene occur in diverse human tumour types , 1989, Nature.

[79]  L. Salford,et al.  Trisomy 7 and sex chromosome loss in human brain tissue. , 1989, Cytogenetics and cell genetics.

[80]  Y. Nakamura,et al.  Loss of heterozygosity for loci on chromosome 17p in human malignant astrocytoma. , 1989, Cancer research.

[81]  B. Henderson,et al.  Risk factors for gliomas and meningiomas in males in Los Angeles County. , 1989, Cancer research.

[82]  P. Black,et al.  Loss of distinct regions on the short arm of chromosome 17 associated with tumorigenesis of human astrocytomas. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[83]  P. Kelly,et al.  A cytogenetic study of 53 human gliomas. , 1989, Cancer genetics and cytogenetics.

[84]  Z. D. Sharp,et al.  Proto-oncogene analyses in brain tumors. , 1989, Journal of neurosurgery.

[85]  Y. Nakamura,et al.  Allelotype of colorectal carcinomas. , 1989, Science.

[86]  C. James,et al.  Mitotic recombination of chromosome 17 in astrocytomas. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[87]  Y. Nakamura,et al.  Loss of heterozygosity on chromosome 10 in human glioblastoma multiforme. , 1989, Genomics.

[88]  M. Matsumura,et al.  Microrecording for the study of thalamic organization, for tumor biopsy and removal. , 1989, Stereotactic and functional neurosurgery.

[89]  M. Khoury,et al.  On the measurement of susceptibility to genetic factors , 1989, Genetic epidemiology.

[90]  C. James,et al.  Clonal genomic alterations in glioma malignancy stages. , 1988, Cancer research.

[91]  W. Blattner,et al.  A cancer family syndrome in twenty-four kindreds. , 1988, Cancer research.

[92]  B. Vogelstein,et al.  Gene Amplification in Malignant Human Gliomas: Clinical and Histopathologic Aspects , 1988, Journal of neuropathology and experimental neurology.

[93]  M. Shibuya,et al.  Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erbB) in human brain tumors , 1988, Molecular and cellular biology.

[94]  Bert Vogelstein,et al.  The GLI gene is a member of the Kruppel family of zinc finger proteins , 1988, Nature.

[95]  R Eldridge,et al.  Neurofibromatosis 2 (bilateral acoustic neurofibromatosis). , 1988, The New England journal of medicine.

[96]  R. Lewis.  Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17 , 1988 .

[97]  J. Rey,et al.  Chromosomal patterns in human malignant astrocytomas. , 1987, Cancer genetics and cytogenetics.

[98]  C. Begg,et al.  Human hypervariable sequences in risk assessment: rare Ha-ras alleles in cancer patients. , 1987, Environmental health perspectives.

[99]  K. Kinzler,et al.  Relationship between gene amplification and chromosomal deviations in malignant human gliomas. , 1987, Cancer genetics and cytogenetics.

[100]  F. McCormick,et al.  A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants. , 1987, Science.

[101]  K. Kinzler,et al.  Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[102]  J. Haines,et al.  Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22 , 1987, Nature.

[103]  F. C. Lucibello,et al.  Localization of the gene for familial adenomatous polyposis on chromosome 5 , 1987, Nature.

[104]  M. Pericak-Vance,et al.  Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene , 1987, Cell.

[105]  Y. Nakamura,et al.  Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17. , 1987, Science.

[106]  A. Miller,et al.  An exploratory case-control study of brain tumors in adults. , 1987, Journal of the National Cancer Institute.

[107]  C. Bird,et al.  Hodgkin's disease: case control epidemiological study in Yorkshire. , 1987, British Journal of Cancer.

[108]  B. Reid,et al.  Hereditary Gastrointestinal Polyposis Syndromes , 1986, The American journal of surgical pathology.

[109]  A. Rubenstein.  Neurofibromatosis: A Review of the Clinical Problem , 1986, Annals of the New York Academy of Sciences.

[110]  J. Mulvihill,et al.  Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. , 1986, The New England journal of medicine.

[111]  M. Deutsch,et al.  Neurofibromatosis and childhood tumors , 1986, Cancer.

[112]  D. Boehme,et al.  Turcot syndrome (glioma polyposis). Case report. , 1985, Journal of neurosurgery.

[113]  C. C. Tijssen.  Genetic Aspects of Brain Tumors — Tumors of Neuroepithelial and Meningeal Tissue , 1985 .

[114]  Hermona Soreq,et al.  Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin , 1985, Nature.

[115]  H. Lynch,et al.  Genetics and Colorectal Cancer1 , 1985 .

[116]  J. Flannery,et al.  Cancer in relatives of children with central-nervous-system neoplasms. , 1984, The New England journal of medicine.

[117]  K. Toomey,et al.  Turcot's syndrome evidence for autosomal dominant inheritance , 1983, Cancer.

[118]  C. C. Tijssen,et al.  Familial Brain Tumours: A Commented Register , 1982 .

[119]  J. Fraumeni,et al.  Prospective study of a family cancer syndrome. , 1982, JAMA.

[120]  K. Takakura,et al.  [Epidemiology of brain tumors (author's transl)]. , 1982, No to shinkei = Brain and nerve.

[121]  Cornelis C. Tijssen,et al.  Familial Brain Tumors , 1982, Developments in Oncology.

[122]  J. Mulvihill,et al.  Malignancy in neurofibromatosis. , 1985, Advances in neurology.

[123]  V. M. Riccardi.  Von Recklinghausen neurofibromatosis. , 1981, The New England journal of medicine.

[124]  H. Lynch,et al.  Genetic and pathologic findings in a kindred with hereditary sarcoma breast cancer, brain tumors, leukemia, lung, laryngeal, and adrenal cortical carcinoma , 1978, Cancer.

[125]  G. Draper,et al.  Occurrence of childhood cancers among sibs and estimation of familial risks. , 1977, Journal of medical genetics.

[126]  H. Lynch,et al.  Familial cancer syndromes: a survey , 1977 .

[127]  F. Li,et al.  Letter: Familial breast cancer, soft-tissue sarcomas, and other neoplasms. , 1975, Annals of internal medicine.

[128]  R. W. Miller.  Deaths from childhood leukemia and solid tumors among twins and other sibs in the United States, 1960-67. , 1971, Journal of the National Cancer Institute.

[129]  L. Schuman,et al.  Epidemiology of primary central nervous system neoplasms. I. Mortality from primary central nervous system neoplasms in Minnesota. , 1970 .

[130]  E. Jackson,et al.  Childhood cancer deaths in california‐born twins. A further report on types of cancer found , 1970, Cancer.

[131]  J. Fraumeni,et al.  Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? , 1969, Annals of internal medicine.

[132]  G. Paulson,et al.  Brain tumors with tuberous sclerosis. , 1967, Journal of neurosurgery.

[133]  B. Harvald,et al.  On the heredity of glioblastoma. , 1956, Journal of the National Cancer Institute.

[134]  W. Schull,et al.  A clinical, pathological, and genetic study of multiple neurofibromatosis , 1956 .